These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 37144811

  • 1. Hypothyroidism in induction chemotherapy of children with acute lymphoblastic leukaemia: A single-centre study.
    Yu H, Han J, Wu X, Qiu Y, Yu H, Xu J, Hao J, Peng Y, Jin R, Zhou F.
    Int J Cancer; 2023 Aug 01; 153(3):669-680. PubMed ID: 37144811
    [Abstract] [Full Text] [Related]

  • 2. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE, Stevenson KE, Vrooman LM, Harris MH, Hunt SK, O'Brien JE, Supko JG, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJ, Lipshultz SE, Kutok JL, Blonquist TM, Neuberg DS, Sallan SE, Silverman LB.
    Lancet Oncol; 2015 Dec 01; 16(16):1677-90. PubMed ID: 26549586
    [Abstract] [Full Text] [Related]

  • 3. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
    Sato A, Hatta Y, Imai C, Oshima K, Okamoto Y, Deguchi T, Hashii Y, Fukushima T, Hori T, Kiyokawa N, Kato M, Saito S, Anami K, Sakamoto T, Kosaka Y, Suenobu S, Imamura T, Kada A, Saito AM, Manabe A, Kiyoi H, Matsumura I, Koh K, Watanabe A, Miyazaki Y, Horibe K.
    Lancet Haematol; 2023 Jun 01; 10(6):e419-e432. PubMed ID: 37167992
    [Abstract] [Full Text] [Related]

  • 4. THYROID DISEASE IN THE LATE OBSERVATION PERIOD UPON CHEMO AND RADIOTHERAPY IN CHILDREN/SURVIVORS OF ACUTE LYMPHOBLASTIC LEUKEMIA.
    Bebeshko VG, Bruslova KM, Lyashenko LO, Tsvіetkova NM, Galkina SG, Yaroshenko ZS, Gonchar LO, Boyarska OY, Kuzmenko VF, Trykhlib IV, Kavardakova NV.
    Probl Radiac Med Radiobiol; 2021 Dec 01; 26():309-318. PubMed ID: 34965557
    [Abstract] [Full Text] [Related]

  • 5. Low absolute neutrophil count during induction therapy is an adverse prognostic factor in childhood acute lymphoblastic leukaemia.
    Chen X, Liu C, Zhang A, Wu W, Liu L, Lan Y, Yi M, Zhang L, Ruan M, Chang L, Zhang L, Zou Y, Chen Y, Yang W, Guo Y, Chen X, Zhang Y, Zhu X.
    Ann Hematol; 2021 Sep 01; 100(9):2269-2277. PubMed ID: 33443592
    [Abstract] [Full Text] [Related]

  • 6. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
    Couturier MA, Huguet F, Chevallier P, Suarez F, Thomas X, Escoffre-Barbe M, Cacheux V, Pignon JM, Bonmati C, Sanhes L, Bories P, Daguindau E, Dorvaux V, Reman O, Frayfer J, Orvain C, Lhéritier V, Ifrah N, Dombret H, Hunault-Berger M, Tanguy-Schmidt A.
    Am J Hematol; 2015 Nov 01; 90(11):986-91. PubMed ID: 26214580
    [Abstract] [Full Text] [Related]

  • 7. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.
    Yang W, Cai J, Shen S, Gao J, Yu J, Hu S, Jiang H, Fang Y, Liang C, Ju X, Wu X, Zhai X, Tian X, Wang N, Liu A, Jiang H, Jin R, Sun L, Yang M, Leung AWK, Pan K, Zhang Y, Chen J, Zhu Y, Zhang H, Li C, Yang JJ, Cheng C, Li CK, Tang J, Zhu X, Pui CH.
    Lancet Oncol; 2021 Sep 01; 22(9):1322-1332. PubMed ID: 34329606
    [Abstract] [Full Text] [Related]

  • 8. Induction Chemotherapy Response in Childhood Acute Lymphoblastic Leukaemia and its Correlation with Cytogenetic and Molecular Features.
    Rana NA, Mahmood A, Robert HM, Zahir S, Ali I, Riaz S.
    J Coll Physicians Surg Pak; 2022 Nov 01; 32(11):1430-1434. PubMed ID: 36377010
    [Abstract] [Full Text] [Related]

  • 9. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
    Vora A, Goulden N, Mitchell C, Hancock J, Hough R, Rowntree C, Moorman AV, Wade R.
    Lancet Oncol; 2014 Jul 01; 15(8):809-18. PubMed ID: 24924991
    [Abstract] [Full Text] [Related]

  • 10. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT, Sabin ND, Reddick WE, Bhojwani D, Liu W, Brinkman TM, Glass JO, Hwang SN, Srivastava D, Pui CH, Robison LL, Hudson MM, Krull KR.
    Lancet Haematol; 2016 Oct 01; 3(10):e456-e466. PubMed ID: 27658980
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic significance and risk factors of minimal residual disease ≥1% on 19th day of induction chemotherapy in children with acute lymphoblastic leukemia].
    Yu J, Yi T, Lin G, Wen J, Chen L, Chen J, Wu X.
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Feb 29; 40(2):255-261. PubMed ID: 32376526
    [Abstract] [Full Text] [Related]

  • 12. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
    Conter V, Valsecchi MG, Buldini B, Parasole R, Locatelli F, Colombini A, Rizzari C, Putti MC, Barisone E, Lo Nigro L, Santoro N, Ziino O, Pession A, Testi AM, Micalizzi C, Casale F, Pierani P, Cesaro S, Cellini M, Silvestri D, Cazzaniga G, Biondi A, Basso G.
    Lancet Haematol; 2016 Feb 29; 3(2):e80-6. PubMed ID: 26853647
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of Factors Influencing Prognosis of 87 Adults with Ph Chromosome Negative ALL].
    Li J, Zhang ZB, Liu ZR, Yang M, Nie YX, Wu MM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug 29; 26(4):1011-1015. PubMed ID: 30111399
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
    Badowska W.
    Med Wieku Rozwoj; 2008 Aug 29; 12(4 Pt 2):1001-7. PubMed ID: 19531816
    [Abstract] [Full Text] [Related]

  • 15. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.
    Bertaina A, Vinti L, Strocchio L, Gaspari S, Caruso R, Algeri M, Coletti V, Gurnari C, Romano M, Cefalo MG, Girardi K, Trevisan V, Bertaina V, Merli P, Locatelli F.
    Br J Haematol; 2017 Feb 29; 176(4):629-636. PubMed ID: 28116786
    [Abstract] [Full Text] [Related]

  • 16. Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma.
    Gao R, Liang JH, Wang L, Zhu HY, Wu W, Wu JZ, Xia Y, Cao L, Fan L, Yang T, Li JY, Xu W.
    Br J Haematol; 2017 Apr 29; 177(1):95-105. PubMed ID: 28146267
    [Abstract] [Full Text] [Related]

  • 17. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study.
    Jabbour E, Short NJ, Ravandi F, Huang X, Daver N, DiNardo CD, Konopleva M, Pemmaraju N, Wierda W, Garcia-Manero G, Sasaki K, Cortes J, Garris R, Khoury JD, Jorgensen J, Jain N, Alvarez J, O'Brien S, Kantarjian H.
    Lancet Haematol; 2018 Dec 29; 5(12):e618-e627. PubMed ID: 30501869
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
    Balduzzi A, Valsecchi MG, Uderzo C, De Lorenzo P, Klingebiel T, Peters C, Stary J, Felice MS, Magyarosy E, Conter V, Reiter A, Messina C, Gadner H, Schrappe M.
    Lancet; 2018 Dec 29; 366(9486):635-42. PubMed ID: 16112299
    [Abstract] [Full Text] [Related]

  • 19. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
    Hann I, Vora A, Harrison G, Harrison C, Eden O, Hill F, Gibson B, Richards S, UK Medical Research Council's Working Party on Childhood Leukaemia.
    Br J Haematol; 2001 Apr 29; 113(1):103-14. PubMed ID: 11328289
    [Abstract] [Full Text] [Related]

  • 20. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
    Liu XM, Chen XJ, Zou Y, Wang SC, Wang M, Zhang L, Chen YM, Yang WY, Guo Y, Zhu XF.
    Zhonghua Er Ke Za Zhi; 2019 Oct 02; 57(10):761-766. PubMed ID: 31594062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.